|Articles|March 1, 2016
- Pharmaceutical Executive-03-01-2016
- Volume 36
- Issue 3
Pharmaceutical Executive, March 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Beyond 2020: Building Strategic Coherence in the New Health Economyover 10 years ago
What Errors Do We Miss in Clinical Trials?over 10 years ago
Data Disclosure: Sealing the Error Envelopeover 10 years ago
Vaccines 2016: Big Bets for Global Threatsover 10 years ago
Drug Delivery Roundtable: More than the Pillover 10 years ago
Orphans of the Stormover 10 years ago
Country Report: The NetherlandsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
2
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
3
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5